Hernández CT, Pérez MY

Language: Spanish
References: 4
Page: 190-193
PDF size: 621.72 Kb.

Text Extraction

No abstract.

REFERENCES

1. Martínez Feria F, Acosta Brooks SC, Cobián Caballero CO. Supervivencia libre de progresión de cáncer pulmonar de células no pequeñas en pacientes vacunados con CIMAvax-EGF. MEDISAN. 2015 [citado 17/05/2016]; 19(12). Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1029-30192015001200007

2. Outsourcing clinical trial safety data management. Clinical Trials. 2014 [citado 09/04/2016]. Disponible en: http://www.sciformix.com/wp-content/uploads/Outsourcing-Clinical-Trial-Safety-Data-Management-July-2014.pdf

3. Lage DA. Immunotherapy and complexity: Overcoming barriers to control of advanced cancer. MEDICC Review. 2014;16 (3-4): 65-72.

4. De la Luz Hernández K, Rabasa Y, Montesinos R, Fuentes D, Santo Tomás JF, Morales O, et al. Cancer vaccine characterization: from bench to clinic. Vaccine. 2014; 32 (24): 2851-8.